原发性肝癌患者外科手术联合介入治疗的应用价值.docVIP

原发性肝癌患者外科手术联合介入治疗的应用价值 南华大学附属第一医院肝胆外科湖南衡阳421001 【摘要】目的探讨原发性肝癌患者外科手术联合介入治疗的应用价值，评估 其临床意义。方法选择我院2011年1月至2013年1月该院收治的120例原发 性肝癌患者作为研究对象，随机平均分为治疗组与对照组，记录术后并发症发生 情况，比较不同阶段接受治疗患者的存活率，对患者治疗后的治疗效果进行评定。 结果治疗组胆胰并发症、上消化道出血、肝动脉瘘、肝癌破裂出血、肝功能袞 竭、3个月内造影残癌和3年内复发病灶等并发症的发生率明显低于对照组， 两组比较存在明显差异(Plt;0.05)o治疗组术后半年、1年、2年、3年的存活 患者均明显高于对照组，两组比较存在明显差异(Plt;0.05)o结论术前先行肝 动脉化疗栓塞术联合介入治疗，可减少术后残余病灶、复发情况等，提高存活率， 具有较好的疗效，值得推广应用。 【关键词】介入治疗；原发性肝癌；肝动脉化疗栓塞术 [AbstractJObjective To investigate the clinical significance of surgical intervention in patients with primary liver cancer.Methods in our hospital in January 2011 to 2013 years 1 month the hospital treated 120 cases of primary liver cancer patients as the object of study were randomly divided into treatment group and control group, to record the postoperative complications，comparing the different stages of accept the survival rate of patients， for patients after treatment, the therapeutic effect was evaluated.Results in the treatment group biliary and pancreatic complications, upper gastrointestinal bleeding, hepatic artery fistula, liver rupture bleeding, liver function failure and 3 months in contrast residual tumor and 3 years recurrence and other complications incidence was significantly lower than that of the control group, two groups compared with the presence of significant difference (P lt; 0.05) .The patients in the treatment group were significantly higher than those in the control group after six months, 1 years, 2 years and 3 years, and there were significant differences between the two groups (Plt;0.05) .Conclusion preoperative transcatheter arterial chemoembolization combined with interventional therapy can reduce postoperative residual lesions，recurrence，improve survival rate，has a good curative effect，it is worth to be popularized. ［keyword］： interventional treatment of primary liver cancer hepatic artery chemoembolization 原发性肝癌(Primary Hepatic Carcinoma, PHC)是继胃癌和食管癌 之后位居第三位的恶性肿瘤，发病率在我国呈上升趋势，因其病情发展速度快、 治疗困难、存活期短、被称作“癌中之王”［1］。肝部分切除术(